CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
m-RESIST focuses on developing a mobile health intervention for patients with resistant schizophrenia, promoting self-management and active participation in treatment. The program aims to enhance patient engagement and improve treatment outcomes through personalized support.
In European Union approximately 5 million people suffer from psychotic disorders.
Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant.
These patients present persistent positive symptomatology, require extensive periods of hospital care, and have a greater risk of excess mortality and multi-morbidity.
In addition, a high proportion of the total cost for treating schizophrenia is spent on this population (Kennedy et al., 2013).Intervention strategies based on mHeal…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Finland, Oulu
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
